Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey
- PMID: 29023514
- PMCID: PMC5638517
- DOI: 10.1371/journal.pone.0186332
Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey
Abstract
Background: The aim of this study was to evaluate the knowledge, attitudes and behaviors towards prostate cancer and its prevention.
Methods: A cross-sectional survey was conducted on a random sample of 625 fathers of students attending eight public schools. The self-administered questionnaire included questions on: socio-demographic characteristics, personal and familiar medical history of prostate cancer, knowledge about prostate cancer and the prostate-specific antigen (PSA) test, perception of risk towards prostate cancer, perception of the benefits of having a PSA-test, willingness to receive the PSA-test and sources of and needs of information regarding prostate cancer and the PSA-test.
Results: 72.7% of respondents had heard about the PSA-test and 51.1% of those had heard about it through their physicians. This knowledge was higher: in men with older age, in those that had a higher level of education, in those who had a relative with prostrate problems or prostate cancer and in those with prostate problems. Perceived personal risk of contracting prostate cancer was associated with a higher level of education, in those who had received information about prostate cancer from a physician and in those with prostate problems. Only 29.6% of men had undergone a PSA-test and 59.4% were willing to do so in the future. The significant predictors of the willingness to receive a PSA-test were the belief that the PSA-test was useful, the perception of not very good personal health status, and need of additional information about the PSA-test.
Conclusion: Respondents have a moderate knowledge about prostate cancer and a good propensity to undergo the PSA-test. Therefore, it would be necessary to increase information on the risks of prostate cancer and the benefits of prostate cancer prevention.
Conflict of interest statement
References
-
- Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108. doi: 10.3322/caac.21262 - DOI - PubMed
-
- Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY, et al. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Eur Urol 2016; 70: 862–74. doi: 10.1016/j.eururo.2016.05.043 - DOI - PubMed
-
- AIRTUM Working Group. Italian Cancer figures, report 2016. http://www.registri-tumori.it/PDF/AIOM2016/I_numeri_del_cancro_2016.pdf.
-
- Concato J, Wells CK, Horwitz RI, Penson D, Fincke G, Berlowitz DR, et al. The effectiveness of screening for prostate cancer: a nested case-control study. Arch Intern Med 2006; 166: 38–43. doi: 10.1001/archinte.166.1.38 - DOI - PubMed
-
- Bartsch G, Horninger W, Klocker H, Pelzer A, Bektic J, Oberaigner W, et al.; Tyrol Prostate Cancer Screening Group. Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality. BJU Int 2008; 101: 809–16. doi: 10.1111/j.1464-410X.2008.07502.x - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
